For the great patient commitment, the trends of pharma industry are moving towards the patient reported results, clinical test data for the desired therapies and also multitudes of the patient support programs. The communication between the patients and pharma companies might be restricted; but this industry seems eager to take some action. Such restricted commitment challenge can be contributed to the medication distribution channels and other third party stakeholders such as doctors, pharmacists, healthcare professionals and group shopping companies who procure the medicines on behalf of the healthcare organizations.
Basically, the research and development of drugs is more essential as a foremost action of servicing the patients. But, if the pharma can distribute to supporting these patients should take a perfect medicine at the perfect time that they must take a chance to. At the same time, the drugs do not work in patients those who do not take them.